http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109929844-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-867 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-573 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2019-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109929844-B |
| titleOfInvention | CPVL (chlorinated polyvinyl chloride) inhibitor as glioma prognostic marker and application thereof |
| abstract | The invention relates to the technical field of biology, in particular to a glioma prognostic marker CPVL inhibitor and application thereof, and provides a scheme, an inhibitor of a glioma prognostic marker CPVL, an inhibitor kit and application of the inhibitor of the glioma prognostic marker CPVL in preparation of a medicament for treating glioma. The invention effectively verifies that the CPVL gene participates in the regulation and control of glioma cell apoptosis through an IFN-gamma signal channel, provides theoretical data for the proliferation and apoptosis of glioma cells, and provides a theoretical basis for the proliferation and apoptosis mechanism of glioma cells. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023283556-A3 |
| priorityDate | 2019-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 71.